BLACK DIAMOND THERAPEUTICS, INC. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c5fd8cc1-cd6d-4f02-bd24-92e584922472/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $12.5M | 2025-01-01 – 2025-12-31 | evidence 0001701541-26-000009 |
| FY 2024 | $-78.8M | 2024-01-01 – 2024-12-31 | evidence 0001701541-25-000016 |
| FY 2023 | $-86.5M | 2023-01-01 – 2023-12-31 | evidence 0001701541-24-000011 |
| FY 2022 | $-92.8M | 2022-01-01 – 2022-12-31 | evidence 0001701541-23-000020 |
| FY 2021 | $-126.9M | 2021-01-01 – 2021-12-31 | evidence 0001701541-22-000007 |
| FY 2020 | $-69.6M | 2020-01-01 – 2020-12-31 | evidence 0001701541-21-000018 |
| FY 2019 | $-29.3M | 2019-01-01 – 2019-12-31 | evidence 0001701541-20-000009 |
| FY 2018 | $-8.9M | 2018-01-01 – 2018-12-31 | evidence 0001701541-20-000009 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
BLACK DIAMOND THERAPEUTICS, INC. — all facts · Revenue · Net Income